Tafakkur Academy | Ilmiy nashr

INTEGRATED ENDOSCOPIC AND HISTOPATHOLOGICAL ASSESSMENT OF COLONIC ADENOCARCINOMA: DIAGNOSTIC ACCURACY, BIOLOGICAL FEATURES, AND POPULATION-BASED SCREENING CHALLENGES IN UZBEKISTAN

Muallif: Ergashev Bekzod
Sana : 17.02.2026
Jurnal : 2026-yil, 2-son
2026-yil, 1-son

Abstract. Colonic adenocarcinoma is the most prevalent malignant neoplasm of the large intestine and constitutes a substantial proportion of cancer-related morbidity and mortality worldwide. Despite advances in diagnostic technologies, a considerable number of cases are still detected at advanced stages, particularly in developing countries. One of the most important factors influencing early detection is the effectiveness of integrated diagnostic strategies based on endoscopic visualization and histopathological verification. The aim of this study is to evaluate the diagnostic value of combined endoscopic and morphological approaches in colonic adenocarcinoma, while simultaneously analyzing biological characteristics of the tumor, pathogenetic mechanisms, clinical features, age-related distribution, and epidemiological tendencies, with a special focus on Uzbekistan. This work is based on a critical synthesis of international scientific literature, clinical studies, and epidemiological reports. High diagnostic concordance between these methods significantly increases overall diagnostic accuracy. The study emphasizes that insufficient screening coverage and limited access to high-quality colonoscopy contribute to delayed diagnosis in Uzbekistan. Strengthening population-based screening and improving diagnostic infrastructure are essential to reduce disease burden.

References:
1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424.
2. Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019). Colorectal cancer. The Lancet, 394(10207), 1467–1480.
3. Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61(5), 759–767.
4. Hamilton, S. R., & Aaltonen, L. A. (2000). Pathology and genetics of tumours of the digestive system. World Health Organization Press.
5. Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J. Y., Boelens, P. G., & Watanabe, T. (2015). Colorectal cancer. Nature Reviews Disease Primers, 1, 15065.
6. Levin, B., Lieberman, D. A., McFarland, B., Smith, R. A., Brooks, D., Andrews, K. S., Dash, C., Giardiello, F. M., Glick, S., Levin, T. R., Pickhardt, P., Rex, D. K., Thorson, A., & Winawer, S. J. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology, 134(5), 1570–1595.
7. Markowitz, S. D., & Bertagnolli, M. M. (2009). Molecular origins of cancer: Molecular basis of colorectal cancer. New England Journal of Medicine, 361(25), 2449–2460.
8. Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30.
9. Winawer, S. J., Zauber, A. G., Ho, M. N., O’Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., Ackroyd, F., Shike, M., Kurtz, R. C., Hornsby-Lewis, L., Gerdes, H., Stewart, E. T., & National Polyp Study Workgroup. (1993). Prevention of colorectal cancer by colonoscopic polypectomy. New England Journal of Medicine, 329(27), 1977–1981.
10. Zauber, A. G. (2015). The impact of screening on colorectal cancer mortality and incidence: Has it really made a difference? Gastrointestinal Endoscopy Clinics of North America, 25(4), 689–702.
📄 PDF yuklash
- + ⬇ Yuklab olish ✕ Yopish
Yuqoriga